Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Ur Energy NYSEAMERICAN:URG$1.32 -0.01 (-0.75%) Closing price 07/10/2026 04:10 PM EasternExtended Trading$1.34 +0.02 (+1.44%) As of 07/10/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$524.48 millionConsensus RatingBuyConsensus Price Target$2.57 (+94.4% Upside)Volume4.12 million sharesAverage Volume14.38 million sharesToday's Range$1.31▼$1.36 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Nouveau Monde Graphite NYSE:NMG$1.58 +0.02 (+0.96%) Closing price 07/10/2026 03:59 PM EasternExtended Trading$1.60 +0.01 (+0.63%) As of 07/10/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde GraphiteMarket Capitalization$257.32 millionConsensus RatingBuyConsensus Price Target$4.67 (+194.4% Upside)Volume278,139 sharesAverage Volume602,237 sharesToday's Range$1.55▼$1.613. iBio NASDAQ:IBIO$1.51 0.00 (0.00%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.53 +0.02 (+1.26%) As of 07/10/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBioMarket Capitalization$75.01 millionConsensus RatingBuyConsensus Price Target$5.00 (+231.1% Upside)Volume894,044 sharesAverage Volume1.02 million sharesToday's Range$1.43▼$1.534. Inuvo NYSEAMERICAN:INUV$1.17 +0.08 (+7.34%) Closing price 07/10/2026 04:10 PM EasternExtended Trading$1.16 0.00 (-0.43%) As of 07/10/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). More about InuvoMarket Capitalization$17.34 millionConsensus RatingBuyConsensus Price Target$7.33 (+526.8% Upside)Volume1.82 million sharesAverage Volume235,997 sharesToday's Range$1.15▼$1.375. Stereotaxis NYSEAMERICAN:STXS$1.70 -0.04 (-2.30%) Closing price 07/10/2026 04:10 PM EasternExtended Trading$1.70 0.00 (0.00%) As of 07/10/2026 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about StereotaxisMarket Capitalization$166.15 millionConsensus RatingBuyConsensus Price Target$3.88 (+127.9% Upside)Volume567,751 sharesAverage Volume596,194 sharesToday's Range$1.64▼$1.756. Peraso NASDAQ:PRSO$0.81 -0.01 (-1.28%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.81 0.00 (-0.34%) As of 07/10/2026 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about PerasoMarket Capitalization$11.97 millionConsensus RatingBuyConsensus Price Target$3.00 (+269.5% Upside)Volume210,883 sharesAverage Volume450,620 sharesToday's Range$0.79▼$0.847. Palisade Bio NASDAQ:PALI$1.96 -0.01 (-0.51%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$2.02 +0.06 (+3.11%) As of 07/10/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade BioMarket Capitalization$340.22 millionConsensus RatingBuyConsensus Price Target$8.83 (+350.7% Upside)Volume3.45 million sharesAverage Volume4.56 million sharesToday's Range$1.87▼$1.998. Autolus Therapeutics NASDAQ:AUTL$1.61 -0.08 (-4.73%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.62 +0.00 (+0.31%) As of 07/10/2026 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$428.51 millionConsensus RatingModerate BuyConsensus Price Target$8.75 (+443.5% Upside)Volume1.35 million sharesAverage Volume947,050 sharesToday's Range$1.54▼$1.709. Context Therapeutics NASDAQ:CNTX$0.65 +0.06 (+9.82%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.66 +0.00 (+0.47%) As of 07/10/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$59.99 millionConsensus RatingModerate BuyConsensus Price Target$6.17 (+844.5% Upside)Volume3.90 million sharesAverage Volume5.10 million sharesToday's Range$0.59▼$0.6710. Tenaya Therapeutics NASDAQ:TNYA$0.87 +0.02 (+2.40%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.86 -0.01 (-1.08%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$188.88 millionConsensus RatingModerate BuyConsensus Price Target$4.00 (+359.6% Upside)Volume3.83 million sharesAverage Volume2.53 million sharesToday's Range$0.80▼$0.8911. NervGen Pharma NASDAQ:NGEN$1.88 +0.02 (+1.08%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.94 +0.06 (+2.93%) As of 07/10/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen PharmaMarket Capitalization$151.59 millionConsensus RatingModerate BuyConsensus Price Target$18.00 (+857.4% Upside)Volume785,706 sharesAverage Volume480,269 sharesToday's Range$1.80▼$1.9412. Metagenomi NASDAQ:MGX$1.27 +0.01 (+0.79%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.27 0.00 (0.00%) As of 07/10/2026 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Metagenomi, Inc, a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. More about MetagenomiMarket Capitalization$47.81 millionConsensus RatingModerate BuyConsensus Price Target$7.00 (+451.2% Upside)Volume349,208 sharesAverage Volume172,562 sharesToday's Range$1.22▼$1.3113. enCore Energy NASDAQ:EU$1.32 0.00 (0.00%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.35 +0.03 (+2.20%) As of 07/10/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$256.41 millionConsensus RatingModerate BuyConsensus Price Target$3.83 (+190.4% Upside)Volume2.07 million sharesAverage Volume3.38 million sharesToday's Range$1.30▼$1.3614. DeFi Technologies NASDAQ:DEFT$0.50 +0.00 (+0.44%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.50 0.00 (-0.28%) As of 07/10/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DeFi Technologies, Inc engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. More about DeFi TechnologiesMarket Capitalization$193.79 millionP/E Ratio4.99Consensus RatingModerate BuyConsensus Price Target$2.00 (+300.5% Upside)Volume1.20 million sharesAverage Volume2.59 million shares15. Humacyte NASDAQ:HUMA$0.69 -0.01 (-0.94%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.71 +0.02 (+2.21%) As of 07/10/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. More about HumacyteMarket Capitalization$154.01 millionConsensus RatingModerate BuyConsensus Price Target$6.25 (+801.0% Upside)Volume13.04 million sharesAverage Volume16.96 million sharesToday's Range$0.67▼$0.7416. Biomea Fusion NASDAQ:BMEA$1.32 +0.01 (+0.76%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.27 -0.05 (-3.79%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$95.43 millionConsensus RatingModerate BuyConsensus Price Target$8.50 (+543.9% Upside)Volume1.41 million sharesAverage Volume935,585 sharesToday's Range$1.20▼$1.3317. Black Diamond Therapeutics NASDAQ:BDTX$1.91 +0.03 (+1.60%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.90 0.00 (-0.26%) As of 07/10/2026 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Black Diamond Therapeutics, Inc, a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. More about Black Diamond TherapeuticsMarket Capitalization$109.45 millionConsensus RatingModerate BuyConsensus Price Target$9.83 (+414.8% Upside)Volume1.05 million sharesAverage Volume2.07 million sharesToday's Range$1.81▼$1.9418. SKYX Platforms NASDAQ:SKYX$1.27 +0.10 (+8.55%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.27 +0.00 (+0.39%) As of 07/10/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SKYX Platforms Corp. provides a series of safe-smart platform technologies. The company's first and second-generation technologies enable light fixtures, ceiling fans, and other electrically wired products to be installed and plugged into a ceiling's electrical outlet box. More about SKYX PlatformsMarket Capitalization$170.79 millionConsensus RatingModerate BuyConsensus Price Target$5.00 (+293.7% Upside)Volume2.29 million sharesAverage Volume1.77 million sharesToday's Range$1.16▼$1.2919. ProKidney NASDAQ:PROK$1.76 -0.04 (-2.22%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.78 +0.01 (+0.85%) As of 07/10/2026 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. More about ProKidneyMarket Capitalization$531.62 millionConsensus RatingModerate BuyConsensus Price Target$9.00 (+411.4% Upside)Volume936,949 sharesAverage Volume1.44 million sharesToday's Range$1.70▼$1.7820. MediciNova NASDAQ:MNOV$1.39 +0.01 (+0.72%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.38 0.00 (-0.36%) As of 07/10/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. More about MediciNovaMarket Capitalization$68.42 millionConsensus RatingModerate BuyConsensus Price Target$8.33 (+499.5% Upside)Volume17,590 sharesAverage Volume71,938 sharesToday's Range$1.38▼$1.4121. Nano-X Imaging NASDAQ:NNOX$1.05 -0.12 (-10.26%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.06 +0.00 (+0.48%) As of 07/10/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. More about Nano-X ImagingMarket Capitalization$73.07 millionConsensus RatingModerate BuyConsensus Price Target$4.00 (+281.0% Upside)Volume1.04 million sharesAverage Volume3.89 million sharesToday's Range$1.05▼$1.1922. Gain Therapeutics NASDAQ:GANX$1.80 -0.02 (-1.10%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.81 +0.01 (+0.56%) As of 07/10/2026 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$76.78 millionConsensus RatingModerate BuyConsensus Price Target$7.50 (+316.7% Upside)Volume610,222 sharesAverage Volume1.30 million sharesToday's Range$1.74▼$1.8223. Canaan NASDAQ:CAN$0.31 0.00 (-0.29%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.31 +0.00 (+0.49%) As of 07/10/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Canaan Inc engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. More about CanaanMarket Capitalization$220.95 millionConsensus RatingModerate BuyConsensus Price Target$2.01 (+551.0% Upside)Volume3.67 million sharesAverage Volume10.19 million sharesToday's Range$0.30▼$0.3324. HeartBeam NASDAQ:BEAT$0.60 -0.04 (-5.47%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.62 +0.02 (+2.48%) As of 07/10/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioTelemetry, Inc, a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. More about HeartBeamMarket Capitalization$33.58 millionConsensus RatingModerate BuyConsensus Price Target$4.33 (+616.3% Upside)Volume569,132 sharesAverage Volume487,160 sharesToday's Range$0.59▼$0.6325. Lucid Diagnostics NASDAQ:LUCD$1.00 +0.01 (+0.99%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.01 +0.01 (+1.00%) As of 07/10/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$203.07 millionConsensus RatingModerate BuyConsensus Price Target$4.19 (+318.8% Upside)Volume822,249 sharesAverage Volume1.77 million sharesToday's Range$0.97▼$1.01 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/06 - 07/10 Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing Why WD-40 Is Proving Great Businesses Never Go Out of Style Rocket Lab’s Stock Drop Comes With a Bullish Twist Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs Power Struggle: Wolfspeed Sues Navitas Over AI Chips Pushing the Edge: Super Micro Computer Reboots the AI Landscape Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
